FRG1 over-expression had no effect on expression levels of cytokines and MMPs but FRG1 knockdown, in both the prostate cancer cell lines, led to enhanced expression of MMP1, GM-CSF, PLGF, PDGFA and CXCL1 in DU145 and PC3. This evidence concerns the gene CXCL1 and prostate carcinoma.